Riskpilot← Back to searchSign inGet full accessMerck Life Science Oy
OYActiveY-tunnus 0964765-2Keilaranta 6Wholesale of chemical products · NACE 4685Est. 199412 employees
Revenue 2024
EUR 0
EBITDA margin
—
Equity ratio
77.6%
Financial strength
Net profit 2024
EUR -20,7M
12 employees
| Revenue | EUR 0 | — |
| EBITDA | EUR -20,5M | — |
| Net profit | EUR -20,7M | — |
| Total assets | EUR 11,5M | +23% |
| Equity | EUR 8,9M | +30% |
| Employees | 12 | — |
Legal name
Merck Life Science Oy
Y-tunnus number
0964765-2
Legal form
Osakeyhtiö
NACE code
4685 · Wholesale of chemical products
Founded
20. huhtikuuta 1994
Share capital
EUR 33 638
Employees
12 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimialana on laboratorio- ja muiden kemikaalien, lääkkeiden, tutkimuskäyttöön tarkoitettujen radioaktiivisten ja stabiilien isotooppien sekä laboratoriokäyttöön tarkoitettujen laitteiden ja tarvikkeiden maahantuonti, myynti ja vienti sekä tähän liittyvä huoltotoiminta ja konsultointi. Yhtiö voi toimintaansa varten hankkia kiinteistöjä ja kiinteistöosakkeita.
Address
Keilaranta 6
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 19 968 | 16 567 | 21 354 | 0 | 0 |
| Staff expenses | −1 274 | −1 410 | −1 250 | −1 510 | −1 510 |
| EBITDA | 1 110 | 674 | 1 210 | 0 | −20 465 |
| Depreciation & amort. | — | — | — | −0 | −0 |
| EBIT | 1 110 | 674 | 1 210 | 0 | −20 465 |
| Net financials | −69 | −31 | −20 | 0 | 172 |
| Profit before tax | 1 041 | 643 | 1 190 | 0 | −20 293 |
| Tax | 227 | 130 | 243 | −0 | 441 |
| Net profit | 814 | 513 | 947 | 0 | −20 734 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 5 911 | 6 670 | 7 877 | 9 296 | 11 462 |
| Equity | 3 971 | 4 484 | 5 431 | 6 850 | 8 899 |
| Long-term debt | 166 | 125 | 78 | 0 | 0 |
| Short-term debt | 1 774 | 2 060 | 2 367 | 2 439 | 2 559 |
| Total debt | 1 940 | 2 186 | 2 446 | 2 439 | 2 559 |
EBITDA margin
-2046500500.0%
This company
15.8%
Market median
-12952534910% vs market
20202024
Equity ratio
77.6%
This company
38.2%
Market median
+103% vs market
20202024
Return on equity
-233.0%
This company
18.4%
Market median
-1366% vs market
20202024
Net profit margin
-2073370000.0%
This company
8.1%
Market median
-25597160594% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.29×
This company
0.62×
Market median
+53% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TJ Chief Executive Officer | Chief Executive Officer | 2020 |
| Former (3) | ||
MF Chief Executive Officer | Chief Executive Officer | 2018 – 2020 |
HM Audit | Audit | 2011 – 2023 |
HM Deputy auditor | Deputy auditor | 2011 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2020 | |
| Board of Directors | 2023 | |
| Former (3) | ||
| Board of Directors | 2018 – 2019 | |
| Board of Directors | 2020 – 2020 | |
| Board of Directors | 2019 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Merck Life Science Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tove Johanna Bexar-Hannula | Chief Executive Officer | 0 companies |
| Miguel Fernandez Alcalde | Chief Executive Officer | 0 companies |
| Heli Maria Tuuri | Audit | 0 companies |
| Heidi Marjatta Vierros | Deputy auditor | 0 companies |
| Reijo Sakari Perälä | Board of Directors | 0 companies |
| Renée Christine Tunold | Board of Directors | 0 companies |
| Liisa Helena Hurme | Board of Directors | 0 companies |
| Tiina Marjatta Puhakka | Board of Directors | 0 companies |
| Kaj Tapio Linna | Board of Directors | 0 companies |